Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Precision Medicine in Oncology^®

Breast Cancer

Gastrointestinal Cancer

Precision Medicine in Oncology^®

IASLC Survey Illustrates Current Barriers to Molecular Testing in Lung Cancer

The rate of global molecular testing is low and is limited by a number of factors, including cost, quality, turn-around time, access, and lack of awareness of testing.
Read More >>

FDA Approves Multiple Companion Diagnostics for Olaparib in HRR+ mCRPC

Blood-Based Assay Shows Preliminary Promise as Screening Tool in Cancer Diagnostics

Hard-to-Target WNT Pathway Gets a Fresh Look in Oncology

FDA Approves PD-L1 IHC 28-8 pharmDx as Companion Diagnostic for Nivolumab Plus Ipilimumab in NSCLC

FDA Approves myChoice CDx as Companion Diagnostic for Olaparib in Ovarian Cancer

View More Stories >>

View Conference Coverage

2020 ESMO Breast Cancer Virtual Meeting

2020 ASCO Virtual Scientific Program

2020 International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

2020 AACR Annual Meeting

2020 SGO Annual Meeting

Dr. Dimou on Managing Disease Progression in NSCLC

Dr. Dimou on Emerging Treatment Options in BRAF+ Lung Cancer

Dr. Hughes on Mutational Risk in Oncology

Dr. Banerji on the Clinical Activity of VS-6766/Defactinib in <em>KRAS</em>-Mutant Tumors

OncLive houses thousands of videos that provide updates and information.
See more Videos

IMDC Criteria and Targeted Therapy in mRCC

The IMpower150 Regimen

Combining Targeted Therapies in CLL

Hepatocellular Carcinoma: Antiangiogenic Therapy Options

OncLive houses thousands of videos that provide updates and information.
See more Videos

Emerging Agents for HER2+ mBC: Targeted Therapeutics

Evolving Landscape of HER2-Targeted Therapy in Breast Cancer

TRK Inhibition: Future Challenges and Evolutions

Use of TRK Inhibition in Specific Tumor Types

The Importance and Evolution of NGS Testing

Envisioning Use of TRK Inhibitors in Clinical Practice

TRK Inhibition in CNS Tumors or Metastases

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Program

Treatment of Advanced Head & Neck Squamous Cell Carcinoma

Ezra Cohen, MD; Robert Ferris, MD, PhD, FACS; and Jared Weiss, MD, provide a comprehensive overview of diagnosis and treatment of advanced head and neck squamous cell carcinoma (HNSCC), including multidisciplinary care and emerging evidence surrounding novel therapies. Treatment approaches to HPV-positive and HPV-negative tumors are explored.